Meckler Jeffrey A 的 Form 4 申報
Travere Therapeutics, Inc.（TVTX），2026/9/11 申報
- 申報編號
- 0001506916-26-000004
- 申報時間
- 2026/9/11 16:05 ET
- 交易日
- 2026/9/10
- 申報延遲
- 1 天
- 10b5-1 計畫
- 有勾選
這份申報列了 6 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $134.6 萬。交易後 1 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Meckler Jeffrey ACIK 0001506916 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/9/10 | Common Stock | M行使選擇權取得 | +10,000 | $17.44 | +$174,400 | 101,500 | 直接 | |
| 2026/9/10 | Common Stock | M行使選擇權取得 | +10,000 | $26.52 | +$265,200 | 111,500 | 直接 | |
| 2026/9/10 | Common Stock | S賣出處分 | −1,700 | $65.39F2 | −$111,165.89 | 109,800 | 直接 | |
| 2026/9/10 | Common Stock | S賣出處分 | −1,200 | $66.15F3 | −$79,380 | 108,600 | 直接 | |
| 2026/9/10 | Common Stock | S賣出處分 | −14,000 | $67.46F4 | −$944,487.6 | 94,600 | 直接 | |
| 2026/9/10 | Common Stock | S賣出處分 | −3,100 | $68.09F5 | −$211,072.8 | 91,500 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/9/10 | Common Stock | M行使選擇權處分 | −10,000 | $0.00 | $0 | 0 | 直接 | |
| 2026/9/10 | Common Stock | M行使選擇權處分 | −10,000 | $0.00 | $0 | 0 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The weighted average sale price for the transaction reported was $65.3917, and the range of prices were between $64.835 and $65.81. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The weighted average sale price for the transaction reported was $66.15, and the range of prices were between $65.93 and $66.74. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The weighted average sale price for the transaction reported was $67.4634, and the range of prices were between $66.93 and $67.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The weighted average sale price for the transaction reported was $68.088, and the range of prices were between $67.94 and $68.23. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。